People

Kevin Norrett

Chief business officer of Ovid Therapeutics, joining in July 2026. His prior roles include business development leadership at Soleno Therapeutics, chief operating officer of Codexis, and business and commercial leadership at Sierra Oncology. Holds an MBA from UC Berkeley and an MS in biochemistry and molecular biology from UCLA.